Nonintensive Care Unit Norepinephrine as an Alternative to Terlipressin in Hepatorenal Syndrome–Acute Kidney Injury
Vignesh Rajasekaran, Xingxing S. Cheng, Ethan Akama-Garren, Juan Garcia, Jason Phillips, Kitty Deng, Uerica Wang, Elsa Sola, Sajid Jalil, Paul Kwo, Allison J. Kwong · 2026
Read Nonintensive Care Unit Norepinephrine as an Alternative to Terlipressin in Hepatorenal Syndrome–Acute Kidney Injury by Vignesh Rajasekaran, Xingxing S. Cheng, Ethan Akama-Garren, Juan Garcia, Jason Phillips, Kitty Deng, Uerica Wang, Elsa Sola, Sajid Jalil, Paul Kwo, Allison J. Kwong (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13584103.txt.
Description
Background and AimsTerlipressin is approved in the United States for the treatment of hepatorenal syndrome–acute kidney injury (HRS-AKI). At our institution, low-dose norepinephrine (NE) can be administered outside the intensive care unit (ICU) on a step-down unit for treatment of HRS-AKI.
Catalog record
| CREATOR | Vignesh Rajasekaran, Xingxing S. Cheng, Ethan Akama-Garren, Juan Garcia, Jason Phillips, Kitty Deng, Uerica Wang, Elsa Sola, Sajid Jalil, Paul Kwo, Allison J. Kwong |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |